Novo's Ozempic, Wegovy targeted for medicare price cuts

The U.S. plans to slash the price it pays for the Novo Nordisk A/S blockbusters Ozempic and Wegovy, the latest drugs to be targeted under legislation that's expected to save the government more than $200 billion over a decade.  Novo's …

Ozempic, Wegovy among drugs subject to Medicare price controls

Dr. Alexandra Sowa joins 'Varney & Co.' to discuss weight-loss drugs becoming widely available and RFK Jr.'s push to ban pharmaceutical television ads and processed foods. Highly coveted weight-loss related diabetes drugs produced by Danish …

Ozempic, Wegovy and other new drugs are selected for Medicare's price negotiations

Biden administration picks 15 more drugs for Medicare negotiation

(The Hill) — The Centers for Medicare and Medicaid Services (CMS) has selected 15 more drugs for Medicare price negotiation, announcing the selection two weeks ahead of schedule. Administration officials did not share which drugs had been selected, only …

Medicare to cut costs on 25 drugs, including Wegovy and Ozempic

Popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and drug manufacturers, the Biden administration said Friday.The price negotiations for the …

STAT+: Pharmalittle: We’re reading about Medicare plans to negotiate obesity-drug prices, a Novartis 340B lawsuit, and ...

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still shaping up but we do know that we will be catching up on our reading, …

STAT+: Medicare announces plan to negotiate prices of diabetes, weight loss drugs

WASHINGTON — Medicare officials announced plans to negotiate the prices of blockbuster diabetes and weight loss drugs Ozempic and Wegovy, further complicating big decisions the Trump administration will have to make about how to cover the medications. The …

Novo Nordisk's Ozempic & Wegovy in 2027 Medicare price talks

Novo Nordisk's (NVO) GLP-1 weight loss drugs, Ozempic and Wegovy, will be targeted in the next round of Medicare price negotiations in 2027, along with 13 other medications. Seana Smith and Brad Smith break down the details on Morning Brief. The last …

Lewis: Canada's dying Liberal government may have just saved medicare

Breadcrumb Trail Links Opinion Columnists Ottawa has tried and failed to attach meaningful conditions to health-care funding. This is its best shot at pulling health care back from the abyss. Health Minister Mark Holland rises during question period, …

FDA bans Red Dye No. 3; doctor sentenced for $70 million Medicare fraud scheme; last call for proposals for the 2025 CMS ...

FDA bans FD&C Red No. 3 The U.S. Food and Drug Administration (FDA) issued an order to revoke the authorization for the use of FD&C Red No. 3 (also referred to as Red Dye No. 3, Red Dye 3 and erythrosine) in food and ingested drugs, based on the …